Copyright Reports & Markets. All rights reserved.

Global Computer-Aided Drug Discovery (CADD) Services Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Computer-Aided Drug Discovery (CADD) Services Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Virtual Screening
    • 1.2.3 Molecular Docking
    • 1.2.4 Molecular Modeling
    • 1.2.5 Scaffold Hopping
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Computer-Aided Drug Discovery (CADD) Services Market Share by Application: 2020 VS 2026
    • 1.3.2 Pharmaceutical or Biotechnology Companies
    • 1.3.3 Academic or Research Institutes
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Computer-Aided Drug Discovery (CADD) Services Market Perspective (2015-2026)
  • 2.2 Global Computer-Aided Drug Discovery (CADD) Services Growth Trends by Regions
    • 2.2.1 Computer-Aided Drug Discovery (CADD) Services Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Computer-Aided Drug Discovery (CADD) Services Historic Market Share by Regions (2015-2020)
    • 2.2.3 Computer-Aided Drug Discovery (CADD) Services Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Computer-Aided Drug Discovery (CADD) Services Players by Market Size
    • 3.1.1 Global Top Computer-Aided Drug Discovery (CADD) Services Players by Revenue (2015-2020)
    • 3.1.2 Global Computer-Aided Drug Discovery (CADD) Services Revenue Market Share by Players (2015-2020)
  • 3.2 Global Computer-Aided Drug Discovery (CADD) Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Computer-Aided Drug Discovery (CADD) Services Revenue
  • 3.4 Global Computer-Aided Drug Discovery (CADD) Services Market Concentration Ratio
    • 3.4.1 Global Computer-Aided Drug Discovery (CADD) Services Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Computer-Aided Drug Discovery (CADD) Services Revenue in 2019
  • 3.5 Key Players Computer-Aided Drug Discovery (CADD) Services Area Served
  • 3.6 Key Players Computer-Aided Drug Discovery (CADD) Services Product Solution and Service
  • 3.7 Date of Enter into Computer-Aided Drug Discovery (CADD) Services Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Computer-Aided Drug Discovery (CADD) Services Breakdown Data by Type (2015-2026)

  • 4.1 Global Computer-Aided Drug Discovery (CADD) Services Historic Market Size by Type (2015-2020)
  • 4.2 Global Computer-Aided Drug Discovery (CADD) Services Forecasted Market Size by Type (2021-2026)

5 Computer-Aided Drug Discovery (CADD) Services Breakdown Data by Application (2015-2026)

  • 5.1 Global Computer-Aided Drug Discovery (CADD) Services Historic Market Size by Application (2015-2020)
  • 5.2 Global Computer-Aided Drug Discovery (CADD) Services Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Computer-Aided Drug Discovery (CADD) Services Market Size (2015-2026)
  • 6.2 North America Computer-Aided Drug Discovery (CADD) Services Market Size by Type (2015-2020)
  • 6.3 North America Computer-Aided Drug Discovery (CADD) Services Market Size by Application (2015-2020)
  • 6.4 North America Computer-Aided Drug Discovery (CADD) Services Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Computer-Aided Drug Discovery (CADD) Services Market Size (2015-2026)
  • 7.2 Europe Computer-Aided Drug Discovery (CADD) Services Market Size by Type (2015-2020)
  • 7.3 Europe Computer-Aided Drug Discovery (CADD) Services Market Size by Application (2015-2020)
  • 7.4 Europe Computer-Aided Drug Discovery (CADD) Services Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Computer-Aided Drug Discovery (CADD) Services Market Size (2015-2026)
  • 8.2 China Computer-Aided Drug Discovery (CADD) Services Market Size by Type (2015-2020)
  • 8.3 China Computer-Aided Drug Discovery (CADD) Services Market Size by Application (2015-2020)
  • 8.4 China Computer-Aided Drug Discovery (CADD) Services Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Computer-Aided Drug Discovery (CADD) Services Market Size (2015-2026)
  • 9.2 Japan Computer-Aided Drug Discovery (CADD) Services Market Size by Type (2015-2020)
  • 9.3 Japan Computer-Aided Drug Discovery (CADD) Services Market Size by Application (2015-2020)
  • 9.4 Japan Computer-Aided Drug Discovery (CADD) Services Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Computer-Aided Drug Discovery (CADD) Services Market Size (2015-2026)
  • 10.2 Southeast Asia Computer-Aided Drug Discovery (CADD) Services Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Computer-Aided Drug Discovery (CADD) Services Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Computer-Aided Drug Discovery (CADD) Services Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 AMRI
    • 11.1.1 AMRI Company Details
    • 11.1.2 AMRI Business Overview
    • 11.1.3 AMRI Computer-Aided Drug Discovery (CADD) Services Introduction
    • 11.1.4 AMRI Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2015-2020))
    • 11.1.5 AMRI Recent Development
  • 11.2 Charles River
    • 11.2.1 Charles River Company Details
    • 11.2.2 Charles River Business Overview
    • 11.2.3 Charles River Computer-Aided Drug Discovery (CADD) Services Introduction
    • 11.2.4 Charles River Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2015-2020)
    • 11.2.5 Charles River Recent Development
  • 11.3 Schrödinger
    • 11.3.1 Schrödinger Company Details
    • 11.3.2 Schrödinger Business Overview
    • 11.3.3 Schrödinger Computer-Aided Drug Discovery (CADD) Services Introduction
    • 11.3.4 Schrödinger Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2015-2020)
    • 11.3.5 Schrödinger Recent Development
  • 11.4 Evotec
    • 11.4.1 Evotec Company Details
    • 11.4.2 Evotec Business Overview
    • 11.4.3 Evotec Computer-Aided Drug Discovery (CADD) Services Introduction
    • 11.4.4 Evotec Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2015-2020)
    • 11.4.5 Evotec Recent Development
  • 11.5 Bayers
    • 11.5.1 Bayers Company Details
    • 11.5.2 Bayers Business Overview
    • 11.5.3 Bayers Computer-Aided Drug Discovery (CADD) Services Introduction
    • 11.5.4 Bayers Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2015-2020)
    • 11.5.5 Bayers Recent Development
  • 11.6 GVK Biosciences
    • 11.6.1 GVK Biosciences Company Details
    • 11.6.2 GVK Biosciences Business Overview
    • 11.6.3 GVK Biosciences Computer-Aided Drug Discovery (CADD) Services Introduction
    • 11.6.4 GVK Biosciences Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2015-2020)
    • 11.6.5 GVK Biosciences Recent Development
  • 11.7 AstraZeneca
    • 11.7.1 AstraZeneca Company Details
    • 11.7.2 AstraZeneca Business Overview
    • 11.7.3 AstraZeneca Computer-Aided Drug Discovery (CADD) Services Introduction
    • 11.7.4 AstraZeneca Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2015-2020)
    • 11.7.5 AstraZeneca Recent Development
  • 11.8 BioDuro
    • 11.8.1 BioDuro Company Details
    • 11.8.2 BioDuro Business Overview
    • 11.8.3 BioDuro Computer-Aided Drug Discovery (CADD) Services Introduction
    • 11.8.4 BioDuro Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2015-2020)
    • 11.8.5 BioDuro Recent Development
  • 11.9 BOC Sciences
    • 11.9.1 BOC Sciences Company Details
    • 11.9.2 BOC Sciences Business Overview
    • 11.9.3 BOC Sciences Computer-Aided Drug Discovery (CADD) Services Introduction
    • 11.9.4 BOC Sciences Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2015-2020)
    • 11.9.5 BOC Sciences Recent Development
  • 11.10 Aris Pharmaceuticals
    • 11.10.1 Aris Pharmaceuticals Company Details
    • 11.10.2 Aris Pharmaceuticals Business Overview
    • 11.10.3 Aris Pharmaceuticals Computer-Aided Drug Discovery (CADD) Services Introduction
    • 11.10.4 Aris Pharmaceuticals Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2015-2020)
    • 11.10.5 Aris Pharmaceuticals Recent Development
  • 11.11 ChemDiv
    • 10.11.1 ChemDiv Company Details
    • 10.11.2 ChemDiv Business Overview
    • 10.11.3 ChemDiv Computer-Aided Drug Discovery (CADD) Services Introduction
    • 10.11.4 ChemDiv Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2015-2020)
    • 10.11.5 ChemDiv Recent Development
  • 11.12 RTI International
    • 10.12.1 RTI International Company Details
    • 10.12.2 RTI International Business Overview
    • 10.12.3 RTI International Computer-Aided Drug Discovery (CADD) Services Introduction
    • 10.12.4 RTI International Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2015-2020)
    • 10.12.5 RTI International Recent Development
  • 11.13 XRQTC
    • 10.13.1 XRQTC Company Details
    • 10.13.2 XRQTC Business Overview
    • 10.13.3 XRQTC Computer-Aided Drug Discovery (CADD) Services Introduction
    • 10.13.4 XRQTC Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2015-2020)
    • 10.13.5 XRQTC Recent Development
  • 11.14 Pharmaron
    • 10.14.1 Pharmaron Company Details
    • 10.14.2 Pharmaron Business Overview
    • 10.14.3 Pharmaron Computer-Aided Drug Discovery (CADD) Services Introduction
    • 10.14.4 Pharmaron Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2015-2020)
    • 10.14.5 Pharmaron Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Computer-Aided Drug Discovery (CADD) Services market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Computer-Aided Drug Discovery (CADD) Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Virtual Screening
    Molecular Docking
    Molecular Modeling
    Scaffold Hopping
    Others

    Market segment by Application, split into
    Pharmaceutical or Biotechnology Companies
    Academic or Research Institutes
    Others

    Based on regional and country-level analysis, the Computer-Aided Drug Discovery (CADD) Services market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Computer-Aided Drug Discovery (CADD) Services market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    AMRI
    Charles River
    Schrödinger
    Evotec
    Bayers
    GVK Biosciences
    AstraZeneca
    BioDuro
    BOC Sciences
    Aris Pharmaceuticals
    ChemDiv
    RTI International
    XRQTC
    Buy now